DOWNLOAD GP CME 2010 PROCEEDINGS BOOKLET (18mb PDF)
DOWNLOAD GP CME 2010 PROCEEDINGS BOOKLET (18mb PDF)
DOWNLOAD GP CME 2010 PROCEEDINGS BOOKLET (18mb PDF)
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Main Programme<br />
Main Programme<br />
Friday 10th June 2011<br />
73<br />
Dr Chris Ellis<br />
Assessment of Cardiac Risk<br />
Friday, 10 June 2011 Start 9:50am Duration: 30mins Baytrust Forum<br />
This presentation will explore the important area of Cardiovascular risk assessment in 2011.<br />
Cardiovascular (CVS) Disease is the commonest cause of death and morbidity in New Zealand, as with<br />
the entire Western world. Great strides have been made with the treatment of cardiac disease, with<br />
medication, stents, coronary bypass operations and defibrillators. However, the logical approach to this<br />
pandemic is to focus on the prevention of significant vascular disease in the first place.<br />
Everybody in the community should be advised about protective lifestyle choices: a good diet, regular<br />
exercise, not smoking and not becoming overweight. However, individuals at high CVS risk still need<br />
to be identified and proactively managed, particularly with a statin, before they encounter ill health.<br />
Unfortunately we are not good at accurately determine who is at high risk.<br />
Although the traditional epidemiological-based method of assessing CVS risk is a good place to start,<br />
the currently promoted NZ Guidelines often fail to identify those who actually experience a CVS event.<br />
All clinicians have found shortcomings with these currently promoted methods.<br />
Additional methods of assessing risk include more reliance on the family history, and the genetic drive to<br />
premature atherosclerosis, and a range of specific risk factors such as highly sensitive C reactive protein<br />
and lipoprotein (a). However the concept of ‘individualising’ CVS risk is increasingly gaining support,<br />
for it’s logic and scientific support. The increasing use of calcium scoring and low x-Ray dose CT cardiac<br />
angiography is developing into a far more accurate method of assessing risk, and may well supersede<br />
the currently used methods within a few years.<br />
Notes<br />
Dr Paul Ockelford<br />
Medicopolitical Session - NZMA Chairman’s Address<br />
Friday, 10 June 2011 Start 11:00am Duration: 30mins Baytrust Forum<br />
Notes<br />
09-12 June 2011 | Energy Events Centre | Rotorua
Change language